Fatigue is one of the symptoms people with MS commonly experience, and for some, it’s the symptom that affects them the most. While the experience of fatigue varies from person to person, the effects can be felt both mentally and physically, leading fatigue to impact on daily life.
A recent large-scale study highlights the prevalence of anxiety and depression in people with MS in the UK. Over 4,000 people took part in the survey; making this research significant in terms of results and direct feedback from people with MS.
The Multiple Sclerosis International Federation (MSIF) has published the results of its ‘Is it MS?’ survey. The survey was carried out in early 2012 with over 4000 people taking part, sharing their experience of being diagnosed with MS.
Carers’ wellbeing, confidence and health are at the heart of the new National Carers Strategy. For carers in Ireland, this means recognition and acknowledgement of their role as key care partners.
The wonderful people over at shift.ms have created this fantastic video – watch here.
For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).
© 2010 - 2024 Multiple Sclerosis Society of Ireland